Drug
Bms 914392
Bms 914392: highest development phase Phase 2, developed by Bristol-Myers Squibb. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Bristol-Myers Squibb
Trials
| Drug | Phase | Indication |
|---|---|---|
| BMS-914392 NCT01356914 | Phase 2 | Atrial Fibrillation |
Latest
No recent events.
Follow Bms 914392 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.